Loss of Robustness and Addiction to IGF1 during Early Keratinocyte Transformation by Human Papilloma Virus 16

PLoS ONE

Volumn 2, Issue 7, 2007, Pages

  Geiger, Tamar ^a   Levitzki, Alexander ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; SOMATOMEDIN C;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL DIVISION; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNOBLOTTING; KERATINOCYTE; KINETICS; METABOLISM; PHYSIOLOGY; POLYMERASE CHAIN REACTION; REPORTER GENE; VIROLOGY; VIRUS CELL TRANSFORMATION; VIRUS GENOME;

APOPTOSIS; CELL CYCLE; CELL DIVISION; CELL TRANSFORMATION, VIRAL; EPIDERMAL GROWTH FACTOR; GENES, REPORTER; GENOME, VIRAL; HUMAN PAPILLOMAVIRUS 16; HUMANS; IMMUNOBLOTTING; INSULIN-LIKE GROWTH FACTOR I; KERATINOCYTES; KINETICS; MAP KINASE KINASE 4; P38 MITOGEN-ACTIVATED PROTEIN KINASES; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-AKT; TRANSFECTION;

EID: 67649678649     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0000605     Document Type: Article

References (50)

1. Sanclemente G, Gill DK, (2002) Human papillomavirus molecular biology and pathogenesis. J Eur Acad Dermatol Venereol 16: 231-240.
2. Werness BA, Levine AJ, Howley PM, (1990) Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248: 76-79.
3. Dyson N, Howley PM, Munger K, Harlow E, (1989) The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243: 934-937.
4. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM, (1993) The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75: 495-505.
5. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM, (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129-1136.
6. Boyer SN, Wazer DE, Band V, (1996) E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res 56: 4620-4624.
7. zur Hausen H, (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2: 342-350.
8. Benhar M, Dalyot I, Engelberg D, Levitzki A, (2001) Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress. Mol Cell Biol 21: 6913-6926.
9. Benhar M, Engelberg D, Levitzki A, (2002) ROS, stress-activated kinases and stress signaling in cancer. EMBO Rep 3: 420-425.
10. Ben-Bassat H, Rosenbaum-Mitrani S, Hartzstark Z, Shlomai Z, Kleinberger-Doron N, et al.(1997) Inhibitors of epidermal growth factor receptor kinase and of cyclin-dependent kinase 2 activation induce growth arrest, differentiation, and apoptosis of human papilloma virus 16-immortalized human keratinocytes. Cancer Res 57: 3741-3750.
11. Mitrani-Rosenbaum S, Tsvieli R, (1992) Differential cooperation of a carcinogen with human papillomavirus type 6 and 16 DNAs in in vitro oncogenic transformation. Intervirology 33: 76-85.
12. Durst M, Bosch FX, Glitz D, Schneider A, zur Hausen H, (1991) Inverse relationship between human papillomavirus (HPV) type 16 early gene expression and cell differentiation in nude mouse epithelial cysts and tumors induced by HPV-positive human cell lines. J Virol 65: 796-804.
13. Braun L, Durst M, Mikumo R, Gruppuso P, (1990) Differential response of nontumorigenic and tumorigenic human papillomavirus type 16-positive epithelial cells to transforming growth factor beta 1. Cancer Res 50: 7324-7332.
14. Rey O, Lee S, Park NH, (1999) Impaired nucleotide excision repair in UV-irradiated human oral keratinocytes immortalized with type 16 human papillomavirus genome. Oncogene 18: 6997-7001.
15. Pestell KE, Hobbs SM, Titley JC, Kelland LR, Walton MI, (2000) Effect of p53 status on sensitivity to platinum complexes in a human ovarian cancer cell line. Mol Pharmacol 57: 503-511.
16. Billecke CA, Ljungman ME, McKay BC, Rehemtulla A, Taneja N, et al.(2002) Lack of functional pRb results in attenuated recovery of mRNA synthesis and increased apoptosis following UV radiation in human breast cancer cells. Oncogene 21: 4481-4489.
17. Liu Y, McKalip A, Herman B, (2000) Human papillomavirus type 16 E6 and HPV-16 E6/E7 sensitize human keratinocytes to apoptosis induced by chemotherapeutic agents: roles of p53 and caspase activation. J Cell Biochem 78: 334-349.
18. Appella E, Anderson CW, (2001) Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem 268: 2764-2772.
19. Schuler M, Maurer U, Goldstein JC, Breitenbucher F, Hoffarth S, et al.(2003) p53 triggers apoptosis in oncogene-expressing fibroblasts by the induction of Noxa and mitochondrial Bax translocation. Cell Death Differ 10: 451-460.
20. De Potter IY, Poumay Y, Squillace KA, Pittelkow MR, (2001) Human EGF receptor (HER) family and heregulin members are differentially expressed in epidermal keratinocytes and modulate differentiation. Exp Cell Res 271: 315-328.
21. Edmondson SR, Thumiger SP, Werther GA, Wraight CJ, (2003) Epidermal homeostasis: the role of the growth hormone and insulin-like growth factor systems. Endocr Rev 24: 737-764.
22. Rodeck U, Jost M, Kari C, Shih DT, Lavker RM, et al.(1997) EGF-R dependent regulation of keratinocyte survival. J Cell Sci 110 (Pt 2): 113-121.
23. Fang X, Yu S, LaPushin R, Lu Y, Furui T, et al.(2000) Lysophosphatidic acid prevents apoptosis in fibroblasts via G(i)-protein-mediated activation of mitogen-activated protein kinase. Biochem J 352 Pt 1: 135-143.
24. Pollak MN, Schernhammer ES, Hankinson SE, (2004) Insulin-like growth factors and neoplasia. Nat Rev Cancer 4: 505-518.
25. Krause D, Lyons A, Fennelly C, O'Connor R, (2001) Transient activation of Jun N-terminal kinases and protection from apoptosis by the insulin-like growth factor I receptor can be suppressed by dicumarol. J Biol Chem 276: 19244-19252.
26. Wu Y, Karas M, Dupont J, Zhao H, Toyoshima Y, et al.(2004) Multiple signaling pathways are involved in the regulation of IGF-I receptor inhibition of PTEN-enhanced apoptosis. Growth Horm IGF Res 14: 52-58.
27. Galvan V, Logvinova A, Sperandio S, Ichijo H, Bredesen DE, (2003) Type 1 insulin-like growth factor receptor (IGF-IR) signaling inhibits apoptosis signal-regulating kinase 1 (ASK1). J Biol Chem 278: 13325-13332.
28. Levine AJ, Feng Z, Mak TW, You H, Jin S, (2006) Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways. Genes Dev 20: 267-275.
29. Sherr CJ, Weber JD, (2000) The ARF/p53 pathway. Curr Opin Genet Dev 10: 94-99.
30. Berkovich E, Ginsberg D, (2003) ATM is a target for positive regulation by E2F-1. Oncogene 22: 161-167.
31. Hershko T, Chaussepied M, Oren M, Ginsberg D, (2005) Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F. Cell Death Differ 12: 377-383.
32. Chan WK, Chong T, Bernard HU, Klock G, (1990) Transcription of the transforming genes of the oncogenic human papillomavirus-16 is stimulated by tumor promotors through AP1 binding sites. Nucleic Acids Res 18: 763-769.
33. Chong T, Chan WK, Bernard HU, (1990) Transcriptional activation of human papillomavirus 16 by nuclear factor I, AP1, steroid receptors and a possibly novel transcription factor, PVF: a model for the composition of genital papillomavirus enhancers. Nucleic Acids Res 18: 465-470.
34. Salcedo M, Taja L, Utrera D, Chavez P, Hidalgo A, et al.(2002) Changes in retinoblastoma gene expression during cervical cancer progression. Int J Exp Pathol 83: 275-286.
35. Chen CL, Hsieh FC, Lieblein JC, Brown J, Chan C, et al.(2007) Stat3 activation in human endometrial and cervical cancers. Br J Cancer 96: 591-599.
36. Niu G, Wright KL, Ma Y, Wright GM, Huang M, et al.(2005) Role of Stat3 in regulating p53 expression and function. Mol Cell Biol 25: 7432-7440.
37. Wei LH, Kuo ML, Chen CA, Chou CH, Cheng WF, et al.(2001) The anti-apoptotic role of interleukin-6 in human cervical cancer is mediated by up-regulation of Mcl-1 through a PI 3-K/Akt pathway. Oncogene 20: 5799-5809.
38. Lembo D, Donalisio M, Cornaglia M, Azzimonti B, Demurtas A, et al.(2006) Effect of high-risk human papillomavirus oncoproteins on p53R2 gene expression after DNA damage. Virus Res 122: 189-193.
39. Girinsky T, Koumenis C, Graeber TG, Peehl DM, Giaccia AJ, (1995) Attenuated response of p53 and p21 in primary cultures of human prostatic epithelial cells exposed to DNA-damaging agents. Cancer Res 55: 3726-3731.
40. Fresno Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C, et al.(2004) PI3K/Akt signalling pathway and cancer. Cancer Treat Rev 30: 193-204.
41. Thompson N, Lyons J, (2005) Recent progress in targeting the Raf/MEK/ERK pathway with inhibitors in cancer drug discovery. Curr Opin Pharmacol 5: 350-356.
42. Zhao JJ, Gjoerup OV, Subramanian RR, Cheng Y, Chen W, et al.(2003) Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase. Cancer Cell 3: 483-495.
43. Wang YZ, Wong YC, (1998) Sex hormone-induced prostatic carcinogenesis in the noble rat: the role of insulin-like growth factor-I (IGF-I) and vascular endothelial growth factor (VEGF) in the development of prostate cancer. Prostate 35: 165-177.
44. Nishino T, Pusey CD, Domin J, (2002) Elevated Akt phosphorylation as an indicator of renal tubular epithelial cell stress. J Biol Chem 277: 33943-33949.
45. Mitsiades CS, Mitsiades NS, McMullan CJ, Poulaki V, Shringarpure R, et al.(2004) Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors. Cancer Cell 5: 221-230.
46. Reinmuth N, Liu W, Fan F, Jung YD, Ahmad SA, et al.(2002) Blockade of insulin-like growth factor I receptor function inhibits growth and angiogenesis of colon cancer. Clin Cancer Res 8: 3259-3269.
47. Shen MR, Hsu YM, Hsu KF, Chen YF, Tang MJ, et al.(2006) Insulin-like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by alphavbeta3 integrin signaling. Carcinogenesis 27: 962-971.
48. Weinstein IB, (2002) Cancer. Addiction to oncogenes-the Achilles heal of cancer. Science 297: 63-64.
49. Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, et al.(1995) Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377: 646-649.
50. Hembree JR, Agarwal C, Eckert RL, (1994) Epidermal growth factor suppresses insulin-like growth factor binding protein 3 levels in human papillomavirus type 16-immortalized cervical epithelial cells and thereby potentiates the effects of insulin-like growth factor 1. Cancer Res 54: 3160-3166.